ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
112.70
-4.07 (-3.49%)
At close: Mar 5, 2026, 4:00 PM EST
110.77
-1.93 (-1.71%)
Pre-market: Mar 6, 2026, 8:55 AM EST
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$93,006
Profits / Employee
-$5,140,086
Market Cap
8.92B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Axsome Therapeutics | 925 |
| Madrigal Pharmaceuticals | 915 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
ABVX News
- 6 days ago - 2 Reasons Abivax Stock Could 10X by 2036 - The Motley Fool
- 9 days ago - BTIG Reiterates Buy Rating for Abivax (ABVX) with $150 Price Target | ABVX Stock News - GuruFocus
- 10 days ago - Wedbush Rates Abivax (ABVX) as Underperform with Cautious Outlook - GuruFocus
- 11 days ago - Abivax (ABVX) Highlights Promising Obefazimod Data at ECCO Congress - GuruFocus
- 13 days ago - Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 - GlobeNewsWire
- 16 days ago - Alger Mid Cap Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 23 days ago - Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - The Motley Fool
- 4 weeks ago - Better Long-Term Buy: This Emerging Player or the Industry Leader? - The Motley Fool